---
title: "Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Receives a Buy from Morgan Stanley"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293082988.md"
description: "Morgan Stanley maintained a Buy rating on Jiangsu Hengrui Pharmaceuticals (1276.HK) on July 16, setting a price target of HK$92.00. The stock closed at HK$57.95. Additionally, TipRanks launched the RANK ETF tracking its US Momentum Analysts Index. Current analyst consensus for Hengrui remains a Strong Buy with an average price target of HK$88.58."
datetime: "2026-07-18T00:27:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293082988.md)
  - [en](https://longbridge.com/en/news/293082988.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293082988.md)
generator: "portal-rs"
---

# Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) Receives a Buy from Morgan Stanley

Morgan Stanley analyst maintained a Buy rating on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H on July 16 and set a price target of HK$92.00. The company’s shares closed yesterday at HK$57.95.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Currently, the analyst consensus on Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is a Strong Buy with an average price target of HK$88.58.

### Related Stocks

- [01276.HK](https://longbridge.com/en/quote/01276.HK.md)
- [600276.CN](https://longbridge.com/en/quote/600276.CN.md)
- [MS.US](https://longbridge.com/en/quote/MS.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [MS-O.US](https://longbridge.com/en/quote/MS-O.US.md)
- [MS-Q.US](https://longbridge.com/en/quote/MS-Q.US.md)
- [MS-E.US](https://longbridge.com/en/quote/MS-E.US.md)
- [MS-I.US](https://longbridge.com/en/quote/MS-I.US.md)
- [MS-L.US](https://longbridge.com/en/quote/MS-L.US.md)
- [MS-P.US](https://longbridge.com/en/quote/MS-P.US.md)
- [MS-A.US](https://longbridge.com/en/quote/MS-A.US.md)
- [MS-F.US](https://longbridge.com/en/quote/MS-F.US.md)
- [MS-K.US](https://longbridge.com/en/quote/MS-K.US.md)

## Related News & Research

- [Morgan Stanley shares investing tips for navigating 'short-lived gimmicks' in the bond market](https://longbridge.com/en/news/296819284.md)
- [REG - JTC PLC Morgan Stanley - Holding(s) in Company](https://longbridge.com/en/news/296512109.md)
- [REG - Rotork PLC Morgan Stanley - Holding(s) in Company](https://longbridge.com/en/news/296812527.md)
- [Morgan Stanley trims Nagarro voting rights to 10.6% from 10.69%](https://longbridge.com/en/news/297213774.md)
- [Morgan Stanley lifts C&A Modas stake to 5.1% via shares and derivatives](https://longbridge.com/en/news/297040655.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**